Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sage Therapeutics

8.80
+0.04000.46%
Post-market: 8.800.00000.00%17:33 EDT
Volume:2.93M
Turnover:25.78M
Market Cap:551.08M
PE:-1.52
High:8.82
Open:8.79
Low:8.76
Close:8.76
Loading ...

Biogen Receives Marketing Authorization Recommendation From European Medicines Agency for Zurzuvae

MT Newswires Live
·
25 Jul

SAGE Therapeutics Inc expected to post a loss of 95 cents a share - Earnings Preview

Reuters
·
25 Jul

Sage Therapeutics Cut to Sector Perform From Sector Outperform by Scotiabank

Dow Jones
·
08 Jul

Scotiabank Downgrades SAGE Therapeutics to Sector Perform From Sector Outperform, Adjusts Price Target to $9.20 From $12

MT Newswires Live
·
08 Jul

U.S. RESEARCH ROUNDUP-Hershey, Metlife, Voya Financial

Reuters
·
08 Jul

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live
·
02 Jul

Sage Therapeutics to Cut Most Jobs Following Acquisition by Supernus Pharmaceuticals

MT Newswires Live
·
01 Jul

Sage Therapeutics cutting over 330 jobs, Boston Globe reports

TIPRANKS
·
01 Jul

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

Reuters
·
23 Jun

Sage Therapeutics price target lowered to $8.50 from $11 at JPMorgan

TIPRANKS
·
23 Jun

J.P. Morgan Remains a Hold on SAGE Therapeutics (SAGE)

TIPRANKS
·
23 Jun

Avidity, BridgeBio, Coty, SAGE, Alkermes: Trending by Analysts

TIPRANKS
·
21 Jun

Sage Therapeutics Is Maintained at Neutral by Baird

Dow Jones
·
20 Jun

Sage Therapeutics price target raised to $9 from $7 at Baird

TIPRANKS
·
20 Jun

Analysts’ Top Healthcare Picks: Surgery Partners (SGRY), SAGE Therapeutics (SAGE)

TIPRANKS
·
18 Jun

H.C. Wainwright sees potential competition for Sage from Biogen

TIPRANKS
·
17 Jun

Sage Therapeutics Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
17 Jun

Sage Therapeutics price target raised to $8.50 from $8 at Canaccord

TIPRANKS
·
17 Jun

U.S. RESEARCH ROUNDUP-Alphabet, Booking Holdings, Meta

Reuters
·
17 Jun

Sage Therapeutics downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
17 Jun